Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms

Journal of the Canadian Urological Association

Volumn 6, Issue 6, 2012, Pages

  Kuyumcuoglu, Ugur ^a   Eryildirim, Bilal ^a   Tuncer, Murat ^a   Faydaci, Gokhan ^a   Tarhan, Fatih ^a   Ozgül, Aydin ^a  

^a Dr Lutfi Kirdar Training and Research Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875083434     PISSN: 19116470     EISSN: None     Source Type: Journal    
DOI: 10.5489/cuaj.145     Document Type: Article

References (17)

1. Deliveliotis C, Chrisofos M, Gougousis E, et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 2006;67:35-9.
2. Sighinolfi MC, Micali S, De Stefani S et al. Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. J Urol 2007;178:229-31.
3. Duvdevani M, Chew BH, Denstedt JD. Minimizing symptoms in patients with ureteric stents. Curr Opin Urol 2006;16:77-82.
4. Barry MJ, Fowler Jr FJ, O'Leary MP, et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 1992;148:1549-57.
5. Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res 2002;11:563-74.
6. Leibovici D, Cooper A, Lindner A, et al. Ureteral stents: morbidity and impact on quality of life. Isr Med Assoc J 2005;7:491-4.
7. Damiano R, Oliva A, Esposito T, et al. Early and late complications of double pigtail ureteral stent. Urol Int 2002;69:136-40.
8. Joshi HB, Stainthorpe A, MacDonagh RP, et al. Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 2003;169:1065-9.
9. Joshi HB, Newns N, Stainthorpe A, et al. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 2003;169:1060-4.
10. Rane A, Saleemi A, Cahill D, et al. Have stent-related symptoms anything to do with placement technique? J Endourol 2001;15:741-5.
11. Ho CH, Chen SC, Chung SD, et al. Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms. J Endourol 2008;22:1427-31.
12. Damiano R, Autorino R, De Sio M, et al. Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol 2005;48:673-8.
13. Irani J, Siquier J, Pirès C, et al. Symptom characteristics and the development of tolerance with time in patients with indwelling double-pigtail ureteric stents. BJU Int 1999;84:276-9.
14. Beddingfield R, Pedro RN, Hinck B, et al. Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 2009;181:170-6.
15. Norris RD, Sur RL, Springhart WP, et al. A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort. Urology 2008;71:792-5.
16. Duvdevani M, Chew BH, Denstedt JD. Minimizing symptoms in patients with ureteric stents. Curr Opin Urol 2006;16:77-82.
17. Beiko DT, Knudsen BE, Denstedt JD. Advances in ureteral stent design. J Endourol 2003;17:195-9.